Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Tavazzi, Luigi"" wg kryterium: Autor


Tytuł:
CARDIAC chronotropic effects of sleep-disordered breathing in patients with heart failure.
Autorzy:
Pinna GD; Department of Biomedical Engineering, Istituti Clinici Scientifici Maugeri, IRCCS Montescano, Montescano, Italy.
La Rovere MT; Department of Cardiology, Istituti Clinici Scientifici Maugeri, IRCCS Montescano, Montescano, Italy.
Robbi E; Department of Cardiology, Istituti Clinici Scientifici Maugeri, IRCCS Montescano, Montescano, Italy.; Sleep Laboratory, Department of Pneumology, Istituti Clinici Scientifici Maugeri, IRCCS Montescano, Montescano, Italy.
Tavazzi L; Maria Cecilia Hospital, GVM Care and Research, Cotignola, Italy.
Maestri R; Department of Biomedical Engineering, Istituti Clinici Scientifici Maugeri, IRCCS Montescano, Montescano, Italy.
Pokaż więcej
Źródło:
Journal of sleep research [J Sleep Res] 2021 Jun; Vol. 30 (3), pp. e13160. Date of Electronic Publication: 2020 Aug 13.
Typ publikacji:
Journal Article
MeSH Terms:
Heart Failure/*complications
Heart Rate/*physiology
Polysomnography/*methods
Sleep Apnea Syndromes/*etiology
Female ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged ; Sleep Apnea Syndromes/physiopathology
Czasopismo naukowe
Tytuł:
Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT.
Autorzy:
Böhm M; Internal Medicine Clinic III, Saarland University Clinic, Saarland University, Homburg, Saar, Germany.
Komajda M; Department of Cardiology, Paris Saint Joseph Hospital, Paris, France.
Borer JS; Howard Gilman and Schiavone Institutes, State University of New York Downstate Medical Center, New York, NY, USA.
Ford I; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
Maack C; Internal Medicine Clinic III, Saarland University Clinic, Saarland University, Homburg, Saar, Germany.; Comprehensive Heart Failure Center, University Clinic Würzburg, Würzburg, Germany.
Tavazzi L; Maria Cecilia Hospital, GVM Care and Research, Ettore Sansavini Health Science Foundation, Cotignola, Italy.
Moyne A; Department of Methodology and Valorisation of Data, International Research Institute Servier, Suresnes, France.
Swedberg K; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; National Heart and Lung Institute, Imperial College London, London, UK.
Pokaż więcej
Corporate Authors:
SHIFT Investigators
Źródło:
European journal of heart failure [Eur J Heart Fail] 2018 Feb; Vol. 20 (2), pp. 373-381. Date of Electronic Publication: 2017 Oct 12.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure, Systolic/*drug therapy
Heart Rate/*drug effects
Ivabradine/*administration & dosage
Stroke Volume/*physiology
Ventricular Function, Left/*drug effects
Cardiovascular Agents/administration & dosage ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Follow-Up Studies ; Heart Failure, Systolic/physiopathology ; Hospitalization/trends ; Humans ; Male ; Middle Aged ; Stroke Volume/drug effects ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Effect of Visit-to-Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) Trial.
Autorzy:
Böhm M; Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany .
Robertson M; Robertson Center for Biostatistics, University of Glasgow, United Kingdom.
Borer J; Division of Cardiovascular Medicine and the Howard Gilman Institute for Heart Valve Disease and the Schiavone Institute for Cardiovascular Translational Research, State University of New York Downstate Medical Center, New York, NY.
Ford I; Robertson Center for Biostatistics, University of Glasgow, United Kingdom.
Komajda M; Institute of Cardiometabolism and Nutrition (ICAN), Pierre et Marie Curie Paris VI University, La Pitié-Salpétrière Hospital, Paris, France.
Mahfoud F; Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany.
Ewen S; Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany.
Swedberg K; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
Tavazzi L; Maria Cecilia Hospital, GVM Care and Research, Ettore Sansavini Health Science Foundation, Cotignola, Italy.
Pokaż więcej
Źródło:
Journal of the American Heart Association [J Am Heart Assoc] 2016 Feb 12; Vol. 5 (2). Date of Electronic Publication: 2016 Feb 12.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Office Visits*
Benzazepines/*therapeutic use
Blood Pressure/*drug effects
Cardiovascular Agents/*therapeutic use
Heart Failure/*drug therapy
Heart Rate/*drug effects
Aged ; Benzazepines/adverse effects ; Cardiovascular Agents/adverse effects ; Double-Blind Method ; Female ; Heart Failure/diagnosis ; Heart Failure/mortality ; Heart Failure/physiopathology ; Hospitalization ; Humans ; Ivabradine ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Predictive Value of Tests ; Risk Assessment ; Risk Factors ; Systole ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial).
Autorzy:
Böhm M; Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Homburg (Saar), Germany. Electronic address: .
Robertson M; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, United Kingdom.
Ford I; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, United Kingdom.
Borer JS; Division of Cardiovascular Medicine, The Howard Gilman Institute for Heart Valve Disease and the Schiavone Institute for Cardiovascular Translational Research, State University of New York Downstate Medical Center, New York, New York.
Komajda M; Institute of Cardiometabolism and Nutrition, Pierre et Marie Curie Paris VI University, La Pitié-Salpétrière Hospital, Paris, France.
Kindermann I; Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Homburg (Saar), Germany.
Maack C; Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Homburg (Saar), Germany.
Lainscak M; Department of Cardiology, General Hospital Celje, Celje, Slovenia.
Swedberg K; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
Tavazzi L; Maria Cecilia Hospital, Gruppo Villa Maria (GVM) Care and Research, Ettore Sansavini Health Science Foundation, Cotignola, Italy.
Pokaż więcej
Źródło:
The American journal of cardiology [Am J Cardiol] 2015 Dec 15; Vol. 116 (12), pp. 1890-7. Date of Electronic Publication: 2015 Oct 09.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Benzazepines/*therapeutic use
Heart Failure, Systolic/*drug therapy
Heart Rate/*drug effects
Myocardial Infarction/*epidemiology
Pulmonary Disease, Chronic Obstructive/*epidemiology
Aged ; Cardiovascular Agents/therapeutic use ; Comorbidity ; Cyclic Nucleotide-Gated Cation Channels/antagonists & inhibitors ; Double-Blind Method ; Female ; Follow-Up Studies ; Global Health ; Heart Failure, Systolic/epidemiology ; Heart Failure, Systolic/physiopathology ; Humans ; Incidence ; Ivabradine ; Male ; Middle Aged ; Survival Rate/trends ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy.
Autorzy:
Böhm M; Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany.
Borer JS
Camm J
Ford I
Lloyd SM
Komajda M
Tavazzi L
Talajic M
Lainscak M
Reil JC
Ukena C
Swedberg K
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2015 May; Vol. 17 (5), pp. 518-26. Date of Electronic Publication: 2015 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Benzazepines/*therapeutic use
Cardiovascular Agents/*therapeutic use
Electrocardiography, Ambulatory/*methods
Heart Failure, Systolic/*drug therapy
Heart Rate/*drug effects
Aged ; Female ; Humans ; Ivabradine ; Male ; Middle Aged ; Prospective Studies
Czasopismo naukowe
Tytuł:
Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure and elevated heart rate: The SHIFT Risk Model.
Autorzy:
Ford I; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK. Electronic address: .
Robertson M; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
Komajda M; Pierre et Marie Curie Paris VI University, La Pitié-Salpétrière Hospital, Paris, France.
Böhm M; Universitätskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany.
Borer JS; Division of Cardiovascular Medicine, The Howard Gilman Institute for Heart Valve Disease and The Schiavone Institute for Cardiovascular Translational Research, State University of New York Downstate Medical Center, NY, USA.
Tavazzi L; Maria Cecilia Hospital, GVM Care and Research, Ettore Sansavini Health Science Foundation, Cotignola, Italy.
Swedberg K; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
Pokaż więcej
Corporate Authors:
SHIFT Investigators
Źródło:
International journal of cardiology [Int J Cardiol] 2015 Apr 01; Vol. 184, pp. 163-169. Date of Electronic Publication: 2015 Feb 04.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Rate*/physiology
Models, Theoretical*
Heart Failure, Systolic/*mortality
Heart Failure, Systolic/*physiopathology
Hospitalization/*trends
Aged ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/mortality ; Atrial Fibrillation/physiopathology ; Chronic Disease ; Double-Blind Method ; Female ; Follow-Up Studies ; Heart Failure, Systolic/diagnosis ; Humans ; Male ; Middle Aged ; Morbidity ; Mortality/trends ; Risk Factors
Czasopismo naukowe
Tytuł:
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT.
Autorzy:
Voors AA
van Veldhuisen DJ
Robertson M
Ford I
Borer JS
Böhm M
Komajda M
Swedberg K
Tavazzi L
Pokaż więcej
Corporate Authors:
SHIFT investigators
Źródło:
European journal of heart failure [Eur J Heart Fail] 2014 Apr; Vol. 16 (4), pp. 426-34.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Benzazepines/*therapeutic use
Cardiovascular Agents/*therapeutic use
Heart Failure/*drug therapy
Heart Rate/*drug effects
Kidney/*physiopathology
Adult ; Aged ; Creatinine/blood ; Cyclic Nucleotide-Gated Cation Channels/antagonists & inhibitors ; Double-Blind Method ; Female ; Glomerular Filtration Rate ; Heart Failure/physiopathology ; Humans ; Ivabradine ; Kidney Diseases ; Male ; Middle Aged
Czasopismo naukowe
Tytuł:
Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties.
Autorzy:
Dobre D; INSERM, Center of Clinical Investigation 9501, Institut Lorrain du Coeur et des Vaisseaux, CHU Nancy, Université de Lorraine, Nancy, France.
Borer JS
Fox K
Swedberg K
Adams KF
Cleland JG
Cohen-Solal A
Gheorghiade M
Gueyffier F
O'Connor CM
Fiuzat M
Patak A
Piña IL
Rosano G
Sabbah HN
Tavazzi L
Zannad F
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2014 Jan; Vol. 16 (1), pp. 76-85. Date of Electronic Publication: 2013 Dec 03.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Adrenergic beta-Antagonists/*therapeutic use
Heart Failure/*drug therapy
Heart Rate/*physiology
Heart Failure/physiopathology ; Heart Rate/drug effects ; Humans ; Prognosis
Czasopismo naukowe
Tytuł:
Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart failure.
Autorzy:
Reil JC; Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Kardiologie, Angiologie und Internistische Intensivmedizin, Homburg/Saar, Germany.
Robertson M
Ford I
Borer J
Komajda M
Swedberg K
Tavazzi L
Böhm M
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2013 Sep; Vol. 15 (9), pp. 1044-52. Date of Electronic Publication: 2013 May 21.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Benzazepines/*therapeutic use
Bundle-Branch Block/*physiopathology
Heart Failure/*drug therapy
Heart Rate/*physiology
Hospitalization/*statistics & numerical data
Aged ; Benzazepines/adverse effects ; Bundle-Branch Block/mortality ; Double-Blind Method ; Female ; Heart Failure/mortality ; Heart Failure/physiopathology ; Humans ; Ivabradine ; Male ; Middle Aged ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study.
Autorzy:
Böhm M; Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Kirrberger Str. 1, 66424, Homburg/Saar, Germany. />Borer J
Ford I
Gonzalez-Juanatey JR
Komajda M
Lopez-Sendon J
Reil JC
Swedberg K
Tavazzi L
Pokaż więcej
Źródło:
Clinical research in cardiology : official journal of the German Cardiac Society [Clin Res Cardiol] 2013 Jan; Vol. 102 (1), pp. 11-22. Date of Electronic Publication: 2012 May 11.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Rate*
Anti-Arrhythmia Agents/*therapeutic use
Benzazepines/*therapeutic use
Heart Failure/*drug therapy
Aged ; Anti-Arrhythmia Agents/adverse effects ; Benzazepines/adverse effects ; Chronic Disease ; Disease Progression ; Double-Blind Method ; Female ; Heart Failure/diagnosis ; Heart Failure/mortality ; Heart Failure/physiopathology ; Hospitalization ; Humans ; Ivabradine ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Patient Selection ; Proportional Hazards Models ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart failure.
Autorzy:
Komajda M; Department of Cardiology, Université Pierre et Marie Curie Paris VI, La Pitié-Salpétrière Hospital, Paris, France. />Böhm M
Borer J
Ford I
Krum H
Tase A
Tavazzi L
Swedberg K
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2013 Jan; Vol. 15 (1), pp. 79-84. Date of Electronic Publication: 2012 Aug 14.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Benzazepines/*therapeutic use
Heart Failure/*drug therapy
Heart Rate/*drug effects
Mineralocorticoid Receptor Antagonists/*administration & dosage
Cyclic Nucleotide-Gated Cation Channels ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Follow-Up Studies ; Heart Failure/physiopathology ; Humans ; Ivabradine ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Autorzy:
Swedberg K; Department of Emergency and Cardiovascular Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden. />Komajda M
Böhm M
Borer JS
Ford I
Dubost-Brama A
Lerebours G
Tavazzi L
Pokaż więcej
Corporate Authors:
SHIFT Investigators
Źródło:
Lancet (London, England) [Lancet] 2010 Sep 11; Vol. 376 (9744), pp. 875-85.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Benzazepines/*therapeutic use
Cardiovascular Agents/*therapeutic use
Heart Failure/*drug therapy
Heart Failure/*mortality
Heart Rate/*drug effects
Sinoatrial Node/*drug effects
Adult ; Aged ; Benzazepines/administration & dosage ; Benzazepines/adverse effects ; Cardiovascular Agents/administration & dosage ; Cardiovascular Agents/adverse effects ; Chronic Disease ; Double-Blind Method ; Electrocardiography ; Female ; Heart Failure/complications ; Heart Failure/physiopathology ; Humans ; Ivabradine ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
Autorzy:
Böhm M; Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany. />Swedberg K
Komajda M
Borer JS
Ford I
Dubost-Brama A
Lerebours G
Tavazzi L
Pokaż więcej
Corporate Authors:
SHIFT Investigators
Źródło:
Lancet (London, England) [Lancet] 2010 Sep 11; Vol. 376 (9744), pp. 886-94.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Benzazepines/*therapeutic use
Cardiovascular Agents/*therapeutic use
Heart Failure/*drug therapy
Heart Failure/*mortality
Heart Rate/*drug effects
Sinoatrial Node/*drug effects
Adult ; Aged ; Benzazepines/administration & dosage ; Benzazepines/adverse effects ; Cardiovascular Agents/administration & dosage ; Cardiovascular Agents/adverse effects ; Chronic Disease ; Double-Blind Method ; Electrocardiography ; Female ; Heart Failure/complications ; Heart Failure/physiopathology ; Humans ; Ivabradine ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Risk Factors ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Tytuł:
24-hour QT variability in heart failure.
Autorzy:
Dobson CP; Children's National Medical Center, Washington, DC, USA.
La Rovere MT
Olsen C
Berardinangeli M
Veniani M
Midi P
Tavazzi L
Haigney M
Pokaż więcej
Corporate Authors:
GISSI-HF Investigators
Źródło:
Journal of electrocardiology [J Electrocardiol] 2009 Nov-Dec; Vol. 42 (6), pp. 500-4. Date of Electronic Publication: 2009 Jul 31.
Typ publikacji:
Journal Article
MeSH Terms:
Heart Rate*
Arrhythmias, Cardiac/*complications
Arrhythmias, Cardiac/*diagnosis
Electrocardiography, Ambulatory/*methods
Heart Failure/*complications
Heart Failure/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Reproducibility of Results ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction.
Autorzy:
Böhm, Michael
Abdin, Amr
Slawik, Jonathan
Mahfoud, Felix
Borer, Jeffrey
Ford, Ian
Swedberg, Karl
Tavazzi, Luigi
Batailler, Cécile
Komajda, Michel
Pokaż więcej
Temat:
HEART failure patients
HEART beat
VENTRICULAR ejection fraction
IVABRADINE
CARDIOVASCULAR disease related mortality
Źródło:
European Journal of Heart Failure; Aug2023, Vol. 25 Issue 8, p1429-1435, 7p, 1 Chart, 4 Graphs
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies